Breast tissue expansion device maker AirXpanders still has about $4.8 million to go to top off a hoped-for $9 million funding, which has attracted 6 unnamed investors so far.
The funding round consists of equity, options to acquire other securities, Series E preferred stock and common stock, according to an SEC filing.